AnterpreetSNekiMD

Oncology • Jacksonville, FL

Assistant Professor, Internal Medicine, Ohio State University College of Medicine

Join to view full profile

Dr. Neki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Neki's full profile

Already have an account?

Office
1301 Palm Ave
Jacksonville, FL 32207
Phone+1 904-202-7300

Fax+1 904-202-7433

Education & Training

Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1996 - 1999
District of Columbia General HospitalResidency, Internal Medicine, 1993 - 1996
Maulana Azad Medical CollegeClass of 1986

Certifications & Licensure

CA State Medical License 2023 - 2025
FL State Medical License 2011 - 2025
OH State Medical License 1997 - 2024
WV State Medical License 2011 - 2013
MI State Medical License 2011 - 2012
PA State Medical License 1997 - 1998
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer Start of enrollment: 2006 Feb 01
Completed
Phase 2

Publications & Presentations

PubMed

6 citations
Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma.
C. Barney, Steve Walston, Pedro Zamora, E. Healy, Nicole Nolan
Oral Oncology. 2018-04-01
21 citations
Phase II Evaluation of Docetaxel-Modulated Capecitabine in Previously Treated Patients with Non–Small Cell Lung Cancer
Tamila Kindwall-Keller, Gregory A. Otterson, Donn C. Young, Anterpreet Neki, Tamara Criswell
Clinical Cancer Research. 2005-03-01
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV...
Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger
Journal of Clinical Oncology. 2024-09-01